KANSAS CITY, Mo., April 16, 2010 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq:CERN) today announced the retirement of Michael E. Herman, one of its long-tenured members of the Board of Directors. His retirement will become effective upon the conclusion of his current Board term in May. Herman has been a director of the company since May 1995 and serves as chairperson of the compensation committee.
Herman's professional experience and community involvement is extensive. From 1966 to 1968, he served as vice president of Laird, Inc. Investment Bankers in New York. In 1968, Herman co-founded Dryden Co., a private investment banking firm also in New York. In 1974, he joined Marion Laboratories, where he was executive vice president and chief financial officer until 1990, a period in which the company experienced explosive growth and success. Herman was president of the entrepreneurially focused Kauffman Foundation from 1985 to 1990 and chairman of its finance and investment committee from 1990 to 1999. He served as president of the Kansas City Royals Baseball Club from 1992 to 2000 and is the president of the Herman Family Trading Company and a director of Santarus, Inc., a biopharmaceutical company, and Senomyx, Inc., a biotechnology company. Herman is a trustee of Rensselaer Polytechnic Institute and the University of Chicago Graduate School of Business.
"Mike has a passion for business. His understanding of what makes entrepreneurs different yet successful has been a great asset to Cerner. On behalf of all of the directors and the management team at Cerner, I want to thank Mike for the many contributions he has made to our success over the past 15 years and his commitment to representing Cerner shareholders," said Neal Patterson, Cerner chairman, CEO and co-founder. "During Mike's tenure with the company, we have faced many significant challenges and opportunities, and the dynamic growth and evolution of the company has been exciting. Mike has played a big part in our success."
"I have had the privilege of working with entrepreneurially based growth companies for the past four decades, as well as being involved with the Kauffman Foundation, perpetuating Ewing Marion Kauffman's legacy of spreading the principles that make entrepreneurs successful," said Herman. "It has been a distinct pleasure to contribute to the direction of Cerner, a Kansas City entrepreneurial company that is making a real mark on the healthcare industry. I came to Cerner 15 years ago when revenues were less than $200 million and leave as revenues approach $2 billion. It's been quite the exciting ride. I look forward to seeing Cerner continue its ascent as a global leader in improving healthcare."
About Cerner
Cerner is transforming healthcare by eliminating error, variance and waste for healthcare providers and consumers around the world. Cerner® solutions optimize processes for healthcare organizations ranging in size from single-doctor practices, to health systems, to entire countries, for the pharmaceutical and medical device industries, and for the healthcare commerce system. These solutions are licensed by more than 8,500 facilities around the world, including approximately 2,300 hospitals; 3,400 physician practices covering more than 30,000 physicians; 600 ambulatory facilities, such as laboratories, ambulatory centers, cardiac facilities, radiology clinics and surgery centers; 700 home-health facilities; and 1,500 retail pharmacies. The trademarks, service marks and logos (collectively, the "Marks") set forth herein are registered and unregistered trademarks and/or service marks owned by Cerner Corporation and/or its subsidiaries in the United States and certain other countries throughout the world. (Nasdaq:CERN). For more information about Cerner, please visit our Web site at www.cerner.com.